TLR ligands

TLR ligands for easy and effective cell activation

  • Immune cell stimulation in human and mouse
  • Ultra-pure and endotoxin-free
  • Potent ligands for guaranteed specificity
Toll-like receptors (TLRs) recognize highly conserved structural motifs as part of the early innate immune response. They recognize a wide variety of ligands expressed exclusively by microbial pathogens, called pathogen-associated molecular patterns (PAMPs). Our TLR ligands are of the highest quality, and are tested rigorously for purity and functionality. Together with our expertise in cell separation, cell analysis, and cell research, our TLR ligands are the most reliable choice for your research.

Product categories

TLR3 Agonists

Synthetic single-stranded RNA oligoribonucleotides (ORNs) mimicking virally derived, double- or single-stranded RNA for the effective activation of immune cells such as dendritic cells and B cells.

TLR7/8 Agonists

High quality ORNs mimicking single-stranded RNA or small synthetic molecules for effective immune cell activation.

TLR9 Agonists

Synthetic oligonucleotides containing CpG motifs (CpG ODNs) that mimic the immune-stimulatory effect of bacterial DNA for effective activation of antigen-presenting cells.

TLR7/8/9 Antagonists

Short single-stranded ODNs with different sequences that effectively neutralize the stimulatory effect of TLR agonists.

Show all TLR Ligands products

Applications

T cells

Dendritic cells, monocytes, macrophages

NK cells

Cancer

Highlights and promotions

Product highlight

TLR7/8 agonists for easy and effective cell activation
Product highlight

MACS® GMP T Cell TransAct™ for in vitro stimulation and expansion of human T cells
Icon_play-xl2_white Created with Sketch.
video preview
Webinar

Human dendritic cell isolation – all you need is blood
Product highlight

TexMACS™ Medium for efficient T cell expansion
Matching products:

Miltenyi Biotec Inc.
phone: +1 800 FOR MACS
fax: + 1 530 745 2806
macs@miltenyibiotec.com

Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.

YouTube Facebook Twitter LinkedIn